Daniel Salomon

Daniel Salomon is an experienced pharmaceutical executive currently serving as General Manager at TempraMed and Chief Commercial Officer at Gericare Pharmaceuticals, where Daniel leads commercial strategy. Prior roles include Executive Vice President at GERITREX CORP, VP of IDNs and Institutional Accounts, and leading various strategic functions at Teva Pharmaceuticals, including post-merger integration and commercial operations in Latin America. Daniel Salomon holds an MBA in Finance & Risk Management from Reichman University and a BSc (Honours) in Management Science from the University of Warwick.